SEC Filings

424B5
AVEXIS, INC. filed this Form 424B5 on 06/22/2017
Entire Document
 

Table of Contents


CAPITALIZATION

          The following table sets forth our cash and cash equivalents and capitalization as of March 31, 2017 on:

    an actual basis; and

    on an as adjusted basis to reflect the issuance and sale by us of 3,575,000 shares of our common stock in this offering, and the receipt of the net proceeds from our sale of these shares, at the public offering price of $70.00 per share, after deducting the underwriting discounts and commissions and offering expenses payable by us (assuming no exercise of the underwriters' option to purchase additional shares).

          You should read this table together with "Management's Discussion and Analysis of Financial Condition and Results of Operations" and our consolidated financial statements and related notes appearing in our Annual Report on Form 10-K for the year ended December 31, 2016 and in our Quarterly Report on Form 10-Q for the quarter ended March 31, 2017, which are incorporated by reference in this prospectus supplement.

 
  As of March 31, 2017  
 
 
Actual
 
As Adjusted
 
 
  (in thousands, except share and per share amounts)
(unaudited)

 

Cash and cash equivalents

  $ 204,454   $ 438,939  

Stockholders' equity

             

Undesignated preferred stock, $0.0001 par value: 10,000,000 shares authorized, no shares issued or outstanding, actual and as adjusted

         

Common stock, $0.0001 par value: 100,000,000 shares authorized, 27,743,174 shares issued and outstanding, actual; 100,000,000 shares authorized, 31,318,174 shares issued and outstanding, as adjusted

    3     3  

Additional paid-in capital

    392,989     627,474  

Accumulated deficit

    (171,281 )   (171,281 )

Total stockholders' equity

    221,711     456,196  

Total capitalization

  $ 221,711   $ 456,196  

          The number of shares of our common stock to be outstanding immediately following this offering as shown above is based on 27,743,174 shares of our common stock outstanding as of March 31, 2017 and excludes:

    2,734,141 shares of common stock issuable upon exercise of outstanding stock options as of March 31, 2017, at a weighted-average exercise price of $25.40 per share;

    106,232 shares of common stock issuable upon the settlement of outstanding restricted stock units as of March 31, 2017;

    305,775 shares of common stock issuable upon the exercise of outstanding warrants as of March 31, 2017, at a weighted-average exercise price of $2.57 per share; and

    up to a maximum of 2,607,080 shares of common stock reserved for future issuance under our 2016 Equity Incentive Plan, or the 2016 Plan, as of March 31, 2017, as well as any automatic increase in the number of shares of common stock reserved for future issuance under the 2016 Plan.

S-15



© AveXis, Inc. All Rights Reserved.